Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

EuroIntervention 2017;12:1595-1604 published online November 2016. DOI: 10.4244/EIJV12I13A262

Jean Fajadet
Jean Fajadet1*, MD; Franz-Josef Neumann2, MD; David Hildick-Smith3, MD; Sonia Petronio4, MD; Azfar Zaman5, MD; Mark Spence6, MD; Jochen Wöhrle7, MD; Simon Elhadad8, MD; David Roberts9, MD; Thomas Hovasse10, MD; Mariano Valdés11, MD; Sigmund Silber12, MD;
1. Clinique Pasteur, Toulouse, France; 2. Universitäts Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany; 3. Royal Sussex County Hospital, Brighton, United Kingdom; 4. Az. Osp. Universitaria Pisana, Pisa, Italy; 5. Freeman Hospital, Newcastle-upo

Aims: The aim of the study was to compare the safety and efficacy of the platinum-chromium-based everolimus-eluting stent (EES) with a cobalt-chromium EES.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary artery diseaseclinical researchmyocardial infarctionpercutaneous coronary interventionstent thrombosis
Coronary interventionsStents and scaffoldsTools, devices and techniques
Read next article
Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program

Latest news